{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:36:59Z","timestamp":1791214619661,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T00:00:00Z","timestamp":1273104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s11910-010-0118-2","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T03:37:20Z","timestamp":1273030640000},"page":"286-291","source":"Crossref","is-referenced-by-count":8,"title":["An Update on Tourette Syndrome"],"prefix":"10.1007","volume":"10","author":[{"given":"Thomas E.","family":"Kimber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,6]]},"reference":[{"key":"118_CR1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archpsyc.1981.01780350025002","volume":"38","author":"DL Pauls","year":"1981","unstructured":"Pauls DL, Cohen DJ, Heimbuch R, et al.: Familial pattern and transmission of Gilles de la Tourette syndrome and multiple tics. Arch Gen Psychiatry 1981, 38:1091\u20131093.","journal-title":"Arch Gen Psychiatry"},{"key":"118_CR2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0022-3956(97)00028-9","volume":"31","author":"J Hebebrand","year":"1997","unstructured":"Hebebrand J, Klug B, Fimmers R, et al.: Rates for tic disorders and obsessive compulsive symptomatology in families of children and adolescents with Gilles de la Tourette syndrome. J Psychiatr Res 1997, 31:519\u2013530.","journal-title":"J Psychiatr Res"},{"key":"118_CR3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archpsyc.1985.01790310077011","volume":"42","author":"RA Price","year":"1985","unstructured":"Price RA, Kidd KK, Cohen DJ, et al.: A twin study of Tourette syndrome. Arch Gen Psychiatry 1985, 42:815\u2013820.","journal-title":"Arch Gen Psychiatry"},{"key":"118_CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/511052","volume":"80","author":"Tourette Syndrome Association International Consortium for Genetics","year":"2007","unstructured":"Tourette Syndrome Association International Consortium for Genetics: Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. Am J Hum Genet 2007, 80:265\u2013272.","journal-title":"Am J Hum Genet"},{"key":"118_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1126\/science.1116502","volume":"310","author":"JF Abelson","year":"2005","unstructured":"Abelson JF, Kwan KY, O\u2019Roak BJ, et al.: Sequence variants in SLITRK1 are associated with Tourette\u2019s syndrome. Science 2005, 310:317\u2013320.","journal-title":"Science"},{"issue":"2","key":"118_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ajmg.1192","volume":"105","author":"I Simonic","year":"2001","unstructured":"Simonic I, Nyholt DR, Gericke GS, et al.: Further evidence for linkage of Gilles de la Tourette syndrome (GTS) susceptibility loci on chromosome 2p11, 8q22 and 11q23-24 in South African Afrikaners. Am J Med Genet 2001, 105(2):163\u2013167.","journal-title":"Am J Med Genet"},{"issue":"4","key":"118_CR7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/303093","volume":"67","author":"C Merette","year":"2000","unstructured":"Merette C, Brassard A, Potvin A ,et al.: Significant linkage for Tourette syndrome in a large French Canadian family. Am J Hum Genet 2000, 67(4):1008\u20131013.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"118_CR8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajmg.a.30928","volume":"138A","author":"A Diaz-Anzaldua","year":"2005","unstructured":"Diaz-Anzaldua A, Riviere J-B, Dube M-P, et al.: Chromosome 11-q24 region in Tourette syndrome: association and linkage disequilibrium study in the French Canadian population. Am J Med Genet Part A 2005, 138A(3):225\u2013228.","journal-title":"Am J Med Genet Part A"},{"key":"118_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.ypg.0000107927.32051.f5","volume":"14","author":"D Curtis","year":"2004","unstructured":"Curtis D, Brett P, Dearlove AM, et al.: Genome scan of Tourette syndrome in a single large pedigree shows some support for linkage to regions of chromosomes 5, 10 and 13. Psychiatr Genet 2004, 14:83\u201387.","journal-title":"Psychiatr Genet"},{"key":"118_CR10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1542\/peds.2004-2058","volume":"116","author":"LK Mell","year":"2005","unstructured":"Mell LK, Davis RL, Owens D: Association between streptococcal infection and obsessive compulsive disorder, Tourette\u2019s syndrome, and tic disorder. Pediatrics 2005, 116:56\u201360.","journal-title":"Pediatrics"},{"key":"118_CR11","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/mds.22504","volume":"24","author":"D Martino","year":"2009","unstructured":"\u2022 Martino D, Dale RC, Gilbert DL, et al.: Immunopathogenic mechanisms in Tourette syndrome: a critical review. Mov Disord 2009, 24:1267\u20131279. This is a comprehensive summary of evidence for the role of infection and autoimmunity in TS.","journal-title":"Mov Disord"},{"key":"118_CR12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archpsyc.60.4.415","volume":"60","author":"BS Peterson","year":"2003","unstructured":"Peterson BS, Thomas P, Kane MJ, et al.: Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 2003, 60:415\u2013424.","journal-title":"Arch Gen Psychiatry"},{"key":"118_CR13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/01.wnl.0000180957.98702.69","volume":"65","author":"M Bloch","year":"2005","unstructured":"Bloch M, Michael H, Leckman JF, et al.: Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005, 65:1253\u20131258.","journal-title":"Neurology"},{"key":"118_CR14","doi-asserted-by":"crossref","first-page":"13307","DOI":"10.1073\/pnas.0502624102","volume":"102","author":"PS Kalanithi","year":"2005","unstructured":"Kalanithi PS, Zheng W, DiFiglia M, et al.: Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 2005, 102:13307\u201313312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"118_CR15","first-page":"89","volume":"99","author":"JW Mink","year":"2006","unstructured":"\u2022\u2022 Mink JW: Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs. Adv Neurol 2006, 99:89\u201398. The author proposes an elegant model to explain the link between basal ganglia neuronal activity and the clinical manifestations of TS.","journal-title":"Adv Neurol"},{"key":"118_CR16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archpsyc.58.5.427","volume":"58","author":"BS Peterson","year":"2001","unstructured":"Peterson BS, Staib L, Scahill L, et al.: Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry 2001, 58:427\u2013440.","journal-title":"Arch Gen Psychiatry"},{"key":"118_CR17","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1176\/appi.ajp.161.11.2028","volume":"161","author":"KJ Plessen","year":"2004","unstructured":"Plessen KJ, Wentzel-Larsen T, Hugdahl K, et al.: Altered interhemispheric connectivity in individuals with Tourette\u2019s disorder. Am J Psychiatry 2004, 161:2028\u20132037.","journal-title":"Am J Psychiatry"},{"key":"118_CR18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archpsyc.64.11.1281","volume":"64","author":"BS Peterson","year":"2007","unstructured":"Peterson BS, Choi HA, Hao X, et al.: Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndrome. Arch Gen Psychiatry 2007, 64:1281\u20131291.","journal-title":"Arch Gen Psychiatry"},{"key":"118_CR19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/nn.2121","volume":"11","author":"ER Sowell","year":"2008","unstructured":"\u2022\u2022 Sowell ER, Kan E, Yoshii J, et al.: Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci 2008, 11:6\u20138. This is an elegant paper on structural cortical changes in children with TS.","journal-title":"Nat Neurosci"},{"key":"118_CR20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cortex.2009.06.008","volume":"46","author":"C Fahim","year":"2010","unstructured":"Fahim C, Yoon U, Das S, et al.: Somatosensory-motor bodily representation cortical thinning in Tourette: effects of tic severity, age and gender. Cortex 2010, 46:750\u2013760.","journal-title":"Cortex"},{"key":"118_CR21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/awn339","volume":"132","author":"G Thomalla","year":"2009","unstructured":"\u2022\u2022 Thomalla G, Siebner HR, Jonas M, et al.: Structural changes in the somatosensory system correlate with tic severity in Gilles de la Tourette syndrome. Brain 2009, 132:765\u2013777. This article confirms structural changes of the cerebral cortex and, in addition, shows a correlation between these changes and symptom severity.","journal-title":"Brain"},{"key":"118_CR22","doi-asserted-by":"crossref","unstructured":"Neuner I, Kupriyanova Y, Stocker T, et al.: White-matter abnormalities in Tourette syndrome extend beyond motor pathways. Neuroimage 2010, Feb 24 (Epub ahead of print; doi: 10.1016\/j.neuroimage.2010.02.049 ).","DOI":"10.1016\/j.neuroimage.2010.02.049"},{"key":"118_CR23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jpsychores.2009.07.024","volume":"67","author":"H Rickards","year":"2009","unstructured":"Rickards H: Functional neuroimaging in Tourette syndrome. J Psychosom Res 2009, 67:575\u2013584.","journal-title":"J Psychosom Res"},{"key":"118_CR24","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/brain\/awl050","volume":"129","author":"S Bohlhalter","year":"2006","unstructured":"\u2022\u2022 Bohlhalter S, Goldfine A, Matteson S, et al.: Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain 2006, 129:2029\u20132037. This article describes cerebral activation patterns both in the premonitory phase of tic generation and at tic onset. Heightened somatosensory and limbic activity in the premonitory phase alters abruptly at the time of tic onset.","journal-title":"Brain"},{"key":"118_CR25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0304-3959(03)00249-5","volume":"105","author":"H Mochizuki","year":"2003","unstructured":"Mochizuki H, Tashiro M, Kano M, et al.: Imaging of central itch modulation in the human brain using positron emission tomography. Pain 2003, 105:339\u2013346.","journal-title":"Pain"},{"key":"118_CR26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1176\/ajp.2007.164.6.955","volume":"164","author":"R Marsh","year":"2007","unstructured":"Marsh R, Zhu H, Wang Z: A developmental fMRI study of regulatory control in Tourette\u2019s syndrome. Am J Psychiatry 2007, 164:955\u2013966.","journal-title":"Am J Psychiatry"},{"key":"118_CR27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/brain\/awn223","volume":"132","author":"JA Church","year":"2009","unstructured":"\u2022 Church JA, Fair DA, Dosenbach NUF, et al.: Control networks in paediatric Tourette syndrome show immature and anomalous patterns. Brain 2009, 132:225\u2013238. The authors present data suggesting there may be a failure of normal cerebral maturation in TS patients.","journal-title":"Brain"},{"key":"118_CR28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1192\/S0007125000297870","volume":"35","author":"S Saxena","year":"1998","unstructured":"Saxena S, Brody AL, Schwartz JM, Baxter LR Jr: Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998, 35:26\u201337.","journal-title":"Br J Psychiatry Suppl"},{"key":"118_CR29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.nrl.0000138734.45742.8d","volume":"10","author":"RJ Morecraft","year":"2004","unstructured":"Morecraft RJ, Stilwell-Morecraft KS, Rossing WR: The motor cortex and facial expression: new insights from neuroscience. Neurologist 2004, 10:235\u2013249.","journal-title":"Neurologist"},{"key":"118_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.chi.0000242242.15421.48","volume":"46","author":"LJ Barnhill Jr","year":"2007","unstructured":"Barnhill LJ Jr: Improvement in speech dysfluency in Tourette\u2019s disorder after tongue piercing. J Am Acad Child Adolesc Psychiatry 2007, 46:3\u20134.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"118_CR31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00004583-198403000-00007","volume":"23","author":"AK Shapiro","year":"1984","unstructured":"Shapiro AK, Shapiro E: Controlled study of pimozide vs placebo in Tourette\u2019s syndrome. J Am Acad Child Adolesc Psychiatry 1984, 23:161\u2013173.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"118_CR32","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archpsyc.1989.01810080052006","volume":"46","author":"E Shapiro","year":"1989","unstructured":"Shapiro E, Shapiro AK, Fulop G, et al.: Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette\u2019s syndrome. Arch Gen Psychiatry 1989, 46:722\u2013730.","journal-title":"Arch Gen Psychiatry"},{"key":"118_CR33","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","volume":"154","author":"FR Sallee","year":"1997","unstructured":"Sallee FR, Nesbitt L, Jackson C, et al.: Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette\u2019s disorder. Am J Psychiatry 1997, 154:1057\u20131062.","journal-title":"Am J Psychiatry"},{"key":"118_CR34","first-page":"377","volume":"35","author":"RL Borison","year":"1982","unstructured":"Borison RL, Ang L, Chang S, et al.: New pharmacological approaches in the treatment of Tourette syndrome. Adv Neurol 1982, 35:377\u2013382.","journal-title":"Adv Neurol"},{"key":"118_CR35","doi-asserted-by":"crossref","first-page":"A506","DOI":"10.1212\/01.WNL.0000106827.39764.7E","volume":"62","author":"YS Silay","year":"2004","unstructured":"Silay YS, Vuong KD, Jankovic J: The efficacy and safety of fluphenazine in patients with Tourette syndrome. Neurology 2004;62: A506.","journal-title":"Neurology"},{"key":"118_CR36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004714-200202000-00006","volume":"22","author":"Y Dion","year":"2002","unstructured":"Dion Y, Annable L, Sandor P, Chouinard G: Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002, 22:31\u201339.","journal-title":"J Clin Psychopharmacol"},{"key":"118_CR37","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1212\/01.WNL.0000055434.39968.67","volume":"60","author":"L Scahill","year":"2003","unstructured":"Scahill L, Leckman JF, Schultz RT, et al.: A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003, 60:1130\u20131135.","journal-title":"Neurology"},{"key":"118_CR38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004583-200003000-00010","volume":"39","author":"FR Sallee","year":"2000","unstructured":"Sallee FR, Kurlan R, Goetz CG, et al.: Ziprasidone treatment of children and adolescents with Tourette\u2019s syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:292\u2013299.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"118_CR39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00449911","volume":"237","author":"CH Eggers","year":"1988","unstructured":"Eggers CH, Rothenberger A, Berghaus U: Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 1988, 237:223\u2013229.","journal-title":"Eur Arch Psychiatry Neurol Sci"},{"key":"118_CR40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1212\/WNL.38.3.391","volume":"38","author":"J Jankovic","year":"1988","unstructured":"Jankovic J, Orman J: Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 1988, 38:391\u2013394.","journal-title":"Neurology"},{"key":"118_CR41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1212\/WNL.48.2.358","volume":"48","author":"J Jankovic","year":"1997","unstructured":"Jankovic J, Beach J: Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997, 48:358\u2013362.","journal-title":"Neurology"},{"key":"118_CR42","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.pediatrneurol.2008.12.014","volume":"40","author":"EF Hedderick","year":"2009","unstructured":"Hedderick EF, Morris CM, Singer HS: Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatr Neurol 2009, 40:420\u2013425.","journal-title":"Pediatr Neurol"},{"key":"118_CR43","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/mds.21615","volume":"22","author":"CL Smith-Hicks","year":"2007","unstructured":"Smith-Hicks CL, Bridges DD, Paynter NP, Singer HS: A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Mov Disord 2007, 22:1764\u20131770.","journal-title":"Mov Disord"},{"key":"118_CR44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","volume":"56","author":"C Marras","year":"2001","unstructured":"Marras C, Andrews D, Sime E, Lang AE: Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001, 56:605\u2013610.","journal-title":"Neurology"},{"issue":"6","key":"118_CR45","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3171\/jns.2003.99.6.1094","volume":"99","author":"V Visser-Vandewalle","year":"2003","unstructured":"Visser-Vandewalle V, Temel Y, Boon P, et al.: Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome: a report of three cases. J Neurosurg 2003, 99(6):1094\u20131100.","journal-title":"J Neurosurg"},{"key":"118_CR46","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/mds.20551","volume":"20","author":"NJ Diederich","year":"2005","unstructured":"Diederich NJ, Kalteis K, Stamenkovic M, et al.: Efficient internal pallidal stimulation in Gilles de la Tourette syndrome: a case report. Mov Disord 2005, 20:1496\u20131499.","journal-title":"Mov Disord"},{"issue":"Suppl","key":"118_CR47","first-page":"E403","volume":"57","author":"AW Flaherty","year":"2005","unstructured":"Flaherty AW, Williams ZM, Amirnovin R, et al.: Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report. Neurosurgery 2005, 57(Suppl):E403.","journal-title":"Neurosurgery"},{"key":"118_CR48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jnnp.2006.104067","volume":"79","author":"D Servello","year":"2008","unstructured":"Servello D, Porta M, Sassi M, et al.: Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry 2008, 79:136\u2013142.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"118_CR49","first-page":"952","volume":"65","author":"M-L Welter","year":"2008","unstructured":"\u2022\u2022 Welter M-L, Mallet L, Houeto J-L, et al.: Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol 2008, 65:952\u2013957. This was the first randomized, double-blind study (albeit in a very small number of patients) to demonstrate the efficacy of DBS in TS.","journal-title":"Arch Neurol"},{"key":"118_CR50","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/mds.21039","volume":"21","author":"JW Mink","year":"2006","unstructured":"Mink JW, Walkup J, Frey KA, et al.: Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord 2006, 21:1831\u20131838.","journal-title":"Mov Disord"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-010-0118-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-010-0118-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-010-0118-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:28:18Z","timestamp":1559435298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-010-0118-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,6]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["118"],"URL":"https:\/\/doi.org\/10.1007\/s11910-010-0118-2","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,6]]}}}